Delivery Order SPE2DB24D2018-SPE2DB25FWWQ0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,173.33 to AmerisourceBergen Drug Corp for the supply of Lonsurf (20 mg-8.19 mg tablets, quantity 60) under a firm fixed price contract type. The award, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, represents a non-set-aside competitive procurement. This delivery order is executed under AmerisourceBergen's Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of LONSURF (20 mg-8.19 mg tablets, 60-count packages) with a ceiling value of $10,173.33. This competitively awarded, non-set-aside contract is scheduled for completion by September 30, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,092.24, is for the delivery of LONSURF 15 MG-6.14 MG tablets. The contract has an ultimate completion date of April 22, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $10,173.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of LONSURF (trifluridine/tipiracil) 20 mg-8.19 mg tablets in quantities of 60 units. This delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), is scheduled for completion by September 30, 2025, with performance at the vendor's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Lonsurf (20 mg–8.19 mg tablets) in a 60-count package with a ceiling value of $10,173.33 under firm fixed-price terms. This is a non-set-aside competitive award with an ultimate completion date of October 3, 2025, and will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under a larger Indefinite Delivery Contract...
- This is a $7,685.32 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LONSURF 15 MG-6.14 MG tablets, which are used for medical treatment. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $6,378.67 firm fixed price delivery order to Amerisourcebergen Drug Corp, a leading pharmaceutical distributor, for the supply of LONSURF 20 MG-8.19 MG TABLET 40S. This order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential total value of $999,999,999.00 and a period of performance through December 31, 2025. The IDC serves as the primary vehicle for...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $6,429.34 contract is for the supply of the drug LONSURF 20 MG-8.19 MG TABLET 20S, with a completion date of February 27, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $4,835.01 firm fixed price delivery order is for the supply of 4564118881 - LONSURF 15 MG-6.14 MG TABLET 40S, a pharmaceutical product. The contract has an ultimate completion date of April 19, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $19,198.52 firm fixed price delivery order contract to supply 60 tablets of the medication LONSURF 20 MG-8.19 MG. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 and awarded solely to Amerisourcebergen Drug Corp, which serves as the prime contractor for providing pharmaceuticals and medical supplies to DLA Troop Support...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWWQ0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,224.47 to AmerisourceBergen Drug Corp for LONSURF (15 mg-6.14 mg tablets, 60-count supply) with an ultimate completion date of September 29, 2025. This is a firm fixed-price, non-set-aside contract utilizing a competitive award process. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order represents a continuation of AmerisourceBergen's substantial role as a prime vendor under the DLA Troop Support Medical Indefinite Delivery Contract (SPE2DX), valued at $999,999,999.00 through December 2026. The underlying IDC provides comprehensive global pharmaceutical support to federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard, covering a diverse portfolio of brand-name and generic medications, vaccines, specialty pharmaceuticals, and medical supplies. The firm's demonstrated capability to fulfill federal requirements through open competition across multiple therapeutic domains and delivery scales positions it as a key supplier within the military healthcare logistics infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 9/8/25 |